Metraipolis › archive › dc_0645e04e6bdc

The Use of Rituximab in Glomerulonephritis: What Is the Evidence? — Europe PMC PMID:41007719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007719
DOI
10.3390/biomedicines13092157
License (as archived)
solo-consultazione
Archived
2026-11-10T03:20:23.794Z
SHA-256 of the archived text
2fa9f698fe8cf3fcb83e6a2a2e3cf23988f8ec1b248410222fc0a5a91e82ad73
Stable URL of this page
https://metraipolis.com/documento/dc_0645e04e6bdc

How to cite

The Use of Rituximab in Glomerulonephritis: What Is the Evidence? — Europe PMC PMID:41007719 — Europe PMC (en), https://europepmc.org/article/MED/41007719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0645e04e6bdc (Metraipolis archive dc_0645e04e6bdc, sha256 2fa9f698fe8cf3fcb83e6a2a2e3cf23988f8ec1b248410222fc0a5a91e82ad73)
BibTeX
@misc{dc0645e04e6bdc,
  title = {The Use of Rituximab in Glomerulonephritis: What Is the Evidence? — Europe PMC PMID:41007719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0645e04e6bdc; sha256 2fa9f698fe8cf3fcb83e6a2a2e3cf23988f8ec1b248410222fc0a5a91e82ad73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007719. Agents can read the archived copy with the MCP tool read_document.